Bill S.1817 188th (2013 - 2014)
An Act relative to prescription drug adverse event reporting
The committee on Public Health to whom was referred the petition (accompanied by bill, Senate, No. 1029) of John F. Keenan, Daniel A. Wolf, Martin J. Walsh, James M. Murphy and other members of the General Court for legislation relative to prescription drug adverse event reporting (Senate, No. 1817).
- Joint Committee on Public Health
|7/15/2013||Senate||Reported from the committee on Public Health|
|7/15/2013||Senate||New draft of S1029|
|7/15/2013||Senate||Bill reported favorably by committee and referred to the committee on Health Care Financing|
|5/8/2014||House||Reporting date extended to Monday June 30, 2014, pending concurrence|
|7/1/2014||Senate||Accompanied a study order, see S2237|
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.